Matt Chan is a Medical Affairs Partner at Roche since April 2022, bringing expertise from a prior role as a Medical Scientific Liaison at Eisai US from November 2020 to July 2022, where responsibilities included work in the Oncology Department focusing on key products such as Lenvima and Halaven. Additionally, Matt served as a Pre-registration pharmacist at NHS England from June 2019 to July 2020. Educational qualifications include a Master of Pharmacy degree from the University of Nottingham, obtained between 2015 and 2019.
This person is not in the org chart
This person is not in any teams
This person is not in any offices